Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Clinical trial NCT06374602 · RECRUITING
Trial details
- NCT number
- NCT06374602
- Sponsor
- Saint Petersburg State University, Russia
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2026-03-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.